In the January 2016 edition of Financier Worldwide, Dr. Gregory K. Bell discusses how mergers and acquisitions can create shareholder value in the life sciences sector. The roundtable discussion is moderated by James C. Greenwood, President and CEO of the Biotechnology Innovation Organization (BIO). To read the article, click the link below.
CRA engagements win in 2024 GCR Awards
The high-profile acquisition of Activision by Microsoft, which CRA Competition’s teams advised on was named overall Matter of the Year, as well as Matter of...